107 related articles for article (PubMed ID: 15735919)
1. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.
Joensuu H; Kankaanranta L; Seppälä T; Auterinen I; Kallio M; Kulvik M; Laakso J; Vähätalo J; Kortesniemi M; Kotiluoto P; Serén T; Karila J; Brander A; Järviluoma E; Ryynänen P; Paetau A; Ruokonen I; Minn H; Tenhunen M; Jääskeläinen J; Färkkilä M; Savolainen S
J Neurooncol; 2003; 62(1-2):123-34. PubMed ID: 12749708
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.
Capala J; Stenstam BH; Sköld K; Munck af Rosenschöld P; Giusti V; Persson C; Wallin E; Brun A; Franzen L; Carlsson J; Salford L; Ceberg C; Persson B; Pellettieri L; Henriksson R
J Neurooncol; 2003; 62(1-2):135-44. PubMed ID: 12749709
[TBL] [Abstract][Full Text] [Related]
5. Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy.
Kondo N; Kinouchi T; Natsumeda M; Matsuzaki J; Hirata E; Sakurai Y; Okada M; Suzuki M
J Neurooncol; 2024 May; 168(1):91-97. PubMed ID: 38598087
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy.
Fukumura M; Nonoguchi N; Kawabata S; Hiramatsu R; Futamura G; Takeuchi K; Kanemitsu T; Takata T; Tanaka H; Suzuki M; Sampetrean O; Ikeda N; Kuroiwa T; Saya H; Nakano I; Wanibuchi M
Sci Rep; 2023 Jun; 13(1):10173. PubMed ID: 37349515
[TBL] [Abstract][Full Text] [Related]
7. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma.
Kabalka GW; Nichols TL; Smith GT; Miller LF; Khan MK; Busse PM
J Neurooncol; 2003; 62(1-2):187-95. PubMed ID: 12749713
[TBL] [Abstract][Full Text] [Related]
8. A novel method for simultaneously measuring boronophenylalanine uptake in brain tumor cells and number of cells using inductively coupled plasma atomic emission spectroscopy.
Li J; Zhang S; Tang Y; Wang J; Gu W; Wei Y; Tang F; Peng X; Liu J; Wei Y; Zhang S; Gu L; Li Y; Tang F
Appl Radiat Isot; 2024 Mar; 205():111184. PubMed ID: 38215645
[TBL] [Abstract][Full Text] [Related]
9. Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial.
Hideghéty K; Sauerwein W; Wittig A; Götz C; Paquis P; Grochulla F; Haselsberger K; Wolbers J; Moss R; Huiskamp R; Fankhauser H; de Vries M; Gabel D
J Neurooncol; 2003; 62(1-2):145-56. PubMed ID: 12749710
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid-based boron delivery system may help increase the uptake boron for boron neutron capture therapy in veterinary medicine: A preliminary study with normal rat brain cells.
Kusaka S; Morizane Y; Tokumaru Y; Tamaki S; Maemunah IR; Akiyama Y; Sato F; Murata I
Res Vet Sci; 2022 Nov; 148():1-6. PubMed ID: 35523003
[TBL] [Abstract][Full Text] [Related]
11. A critical assessment of boron target compounds for boron neutron capture therapy.
Hawthorne MF; Lee MW
J Neurooncol; 2003; 62(1-2):33-45. PubMed ID: 12749701
[TBL] [Abstract][Full Text] [Related]
12. Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy: 10B concentration predictions and dosimetric consequences.
Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
J Neurooncol; 2003; 62(1-2):171-86. PubMed ID: 12749712
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18 labeling PEGylated 6-boronotryptophan for PET scanning of mice for assessing the pharmacokinetics for boron neutron capture therapy of brain tumors.
Chen XP; Hsu FC; Huang KY; Hsieh TS; Farn SS; Sheu RJ; Yu CS
Bioorg Med Chem Lett; 2024 Jun; 105():129744. PubMed ID: 38614152
[TBL] [Abstract][Full Text] [Related]
14. Permeability of the blood-brain barrier to a rhenacarborane.
Hawkins PM; Jelliss PA; Nonaka N; Shi X; Banks WA
J Pharmacol Exp Ther; 2009 May; 329(2):608-14. PubMed ID: 19179541
[TBL] [Abstract][Full Text] [Related]
15. REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA).
Henriksson R; Capala J; H-Stenstam B; Michanek A; Lindahl SK; Salford L; Franzén L; Blomquist E; Westlin JE; Bergenheim AT
Radiother Oncol; 2006 May; ():150-157. PubMed ID: 16698096
[TBL] [Abstract][Full Text] [Related]
16. Case of Tumour in the Brain.
Smith EG
Med Exam (Phila); 1846 Jan; 2(13):21-25. PubMed ID: 38120145
[No Abstract] [Full Text] [Related]
17. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
[TBL] [Abstract][Full Text] [Related]
19. Quantitative monitoring and modelling of retrodialysis drug delivery in a brain phantom.
Rognin E; Willis-Fox N; Daly R
Sci Rep; 2023 Feb; 13(1):1900. PubMed ID: 36732612
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients.
Portnow J; Badie B; Suzette Blanchard M; Kilpatrick J; Tirughana R; Metz M; Mi S; Tran V; Ressler J; D'Apuzzo M; Aboody KS; Synold TW
Cancer Gene Ther; 2021 Apr; 28(3-4):294-306. PubMed ID: 32895489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
